... Vector is specifically designed to target and ... Saccharomyces cerevisiae. Displayed proteins can be analyzed ... or putative ligands. pYD1 uses the a-agglutinin ... domains Aga1 and Aga2 to display recombinant ...
... 15(S)-15-methyl PGF2α is a metabolically ... is a potent uterine stimulant ... administered intramuscularly to induce labor. ... serum progesterone concentrations when given ...
... media are neutral, porous styrene ... chromatography of lipophilic polymers and ... eluents. The beads are compatible ... tetrachloride, dimethylformamide, ketones, aromatics, methylene ...
... Epitope: A BALB/c mouse was ... Recommended Storage: Store vial at -20 C ... at -20 C or below for extended storage. ... Centrifuge product if not completely clear after standing ...
Biology Products:(Date:12/14/2009)... defining feature of humans. That,s until examples of tool use ... array of other mammals. Now, a report in the December ... publication, adds an octopus to the growing list of tool ... trick that the researchers call stilt walking. In it, the ... makes its eight arms rigid, and raises the whole assembly ...
(Date:12/14/2009)... is in preventing some of the stresses of open surgery ... flow and organ dysfunction. Laparoscopy is a type of surgery ... , By adding another gas to the carbon dioxide ... Duke University Medical Center have found they can preserve more ... ethyl nitrite (ENO) helped to open blood vessels and keep ...
(Date:12/13/2009)... Haven, Conn.A team led by Yale University researchers ... whole blood for the first time. Their findings, ... publication of Nature Nanotechnology , could dramatically ... cancer and other diseases. , The ... of Engineering & Applied Science, and Tarek Fahmy, ...
Breaking Biology News(10 mins):Tool use in an invertebrate: The coconut-carrying octopus 2Gas improves blood flow and organ status during minimally invasive surgery 2Scientists use nanosensors for first time to measure cancer biomarkers in blood 2American Hygiene Habits Getting Worse 3A International Study Reveals More Illness Causing Germs Than Ever in American Kitchens 51732 1American Hygiene Habits Getting Worse 3A International Study Reveals More Illness Causing Germs Than Ever in American Kitchens 51732 2American Hygiene Habits Getting Worse 3A International Study Reveals More Illness Causing Germs Than Ever in American Kitchens 51732 3American Hygiene Habits Getting Worse 3A International Study Reveals More Illness Causing Germs Than Ever in American Kitchens 51732 4Simcere Pharmaceutical Group Notice of Annual General Meeting 13032 1Simcere Pharmaceutical Group Notice of Annual General Meeting 13032 2Grupo Salinas Fundacion Azteca and Mexicos Environmental Ministry Present Ciudades Mas Limpias de Mexico and Recicla 2009 Anti Litter and Recycling C 51728 1Grupo Salinas Fundacion Azteca and Mexicos Environmental Ministry Present Ciudades Mas Limpias de Mexico and Recicla 2009 Anti Litter and Recycling C 51728 2Grupo Salinas Fundacion Azteca and Mexicos Environmental Ministry Present Ciudades Mas Limpias de Mexico and Recicla 2009 Anti Litter and Recycling C 51728 3(Date:12/11/2009)... miRagen Therapeutics, Inc., a biopharmaceutical company focused on ... for cardiovascular and muscle disease, today announced the ... a crucial role in the progression of amyotrophic ... in neuromuscular synaptic regeneration in mice. The ... the journal Science , reveal miR-206 as ...
(Date:12/11/2009)... DIEGO, Dec. 11 Ambit Biosciences Corporation announced ... Texas M. D. Anderson Cancer Center of the first ... Monotherapy E fficacy) Phase 2 pivotal ... leukemia (AML). AC220 is a novel, orally available, ... designed as a FMS-like tyrosine kinase-3 (FLT3) inhibitor. ...
(Date:12/11/2009)... Dec. 11 Gwathmey, Inc., a pre-clinical ... cancer, staph aureus, and cardiovascular disease announces a ... today that Rosalie Dunn, Ph.D., has joined Gwathmey ... over 28 years of experience working with small ... joining Gwathmey, Dr. Dunn managed multimillion dollar portfolios ...
(Date:12/10/2009)... SEATTLE, Dec. 10 Dendreon Corporation (Nasdaq: ... underwritten public offering of 15,000,000 shares of its common ... per share. Dendreon also granted to the underwriters ... 2,250,000 shares of common stock to cover overallotments, if ... December 15, 2009, subject to customary closing conditions. ,, ...
Breaking Biology Technology:miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer 2Dendreon Announces Pricing of Common Stock Offering 2Dendreon Announces Pricing of Common Stock Offering 3